Market Tracker

11/21 6:05pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.6901
Data as of Nov 21
 -0.0189 / -2.67%
Today’s Change
0.37
Today|||52-Week Range
1.85
+35.31%
Year-to-Date

Today’s Trading

Previous close0.71
Today’s open0.71
Day’s range0.69 - 0.71
Volume445,726
Average volume (3 months)1,015,744
Market cap$123.0M
Dividend yield--
Data as of 4:02pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-61.90%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.02

Competitors

 Today’s
change
Today’s
% change
SNSSSunesis Pharmaceutic...+0.05+2.42%
DSCODiscovery Laboratori...-0.01-0.65%
MDWDMediwound Ltd-0.36-6.33%
CRMECardiome Pharma Corp+0.11+1.37%
Data as of 4:00pm ET, 11/21/2014

Financials

Next reporting dateNovember 24, 2014
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts